Impact of dose modification of immune-checkpoint inhibitors in lung cancer patients during the COVID-19 pandemic

Autor:	M Veron, T Pierret, M Perol, J Benet, N Denis, D Moro-Sibilot, A Swalduz, A C Toffart
Rok vydání:	2022
Zdroj:	11.01 - Lung cancer.
DOI:	10.1183/13993003.congress-2022.721
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3b941b4e37a496e046ddf2cd6b59472a https://doi.org/10.1183/13993003.congress-2022.721 Zobrazit plný text záznamu